FDA

Orexigen Therapeutics: FDA Panel Live Blog
TheStreet.com
Tue, 12/7/10 - 07:56 am
FDA
advisory panels
Orexigen
Contrave
obesity
Orexigen braces for advisory panel's Contrave review
Fierce Biotech
Mon, 12/6/10 - 05:04 pm
Orexigen
Contrave
FDA
advisory panels
obesity
FDA: Proposed Weight Loss Drug Contrave Raises Blood Pressure
WSJ Online
Fri, 12/3/10 - 11:06 am
FDA
obesity
Contrave
hypertension
Orexigen
Orexigen's Diet Pill Has Unclear Benefits, an FDA Staff Review Indicates
Bloomberg
Fri, 12/3/10 - 08:46 am
Orexigen
FDA
Contrave
obesity
Orexigen: Don't Count Contrave Out Yet
Seeking Alpha
Fri, 12/3/10 - 06:45 am
FDA
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Vivus
Can there be such a thing as a generic medical device?
Thu, 12/2/10 - 10:02 pm
generics
Group purchasing organizations
FDA
Invisalign maker gets FDA warning on side effects
Thu, 12/2/10 - 09:58 pm
FDA
warning
side effects
Invisalign
Covidien lands FDA clearance for surgical stapler
Thu, 12/2/10 - 09:44 pm
Covidien
surgical stapler
FDA
iDrive
colorectal surgery
AstraZeneca: FDA panel says vandetanib could help some medullary thyroid cancer patients
Yahoo/AP
Thu, 12/2/10 - 06:59 pm
FDA
AstraZeneca
vandetanib
thyroid cancer
Cubist says FDA approves fast-injection Cubicin
Yahoo/AP
Thu, 12/2/10 - 12:59 pm
FDA
Cubist Pharmaceuticals
Cubicin
antibiotics
Are Death Panels For Overpriced Cancer Drugs Coming To The FDA?
Forbes
Thu, 12/2/10 - 12:12 pm
cancer
FDA
advisory panels
Roche
Avastin
Regulatory experts see huge challenges on biosimilar rules
Fierce Biotech
Thu, 12/2/10 - 10:20 am
biosimilars
FDA
Europe
Merck's Proscar Fails to Win U.S. FDA Panel's Backing for Prostate Cancer
Bloomberg
Wed, 12/1/10 - 05:55 pm
Merck
Proscar
FDA
prostate cancer
Allergan Lap-Band Effective in Treating More Obese People, FDA Staff Says
Bloomberg
Wed, 12/1/10 - 11:29 am
Allergan
obesity
Lap-Band
FDA
Tylenol plant still plagued by FDA violations
CNN Money
Wed, 12/1/10 - 11:25 am
JNJ
recalls
FDA
Tylenol
Consumers, companies see room to improve at FDA
Tue, 11/30/10 - 03:07 pm
FDA
approvals
FDA disputes prostate drugs' risk-cutting power
Fierce Pharma
Tue, 11/30/10 - 10:59 am
FDA
GSK
prostate cancer
Avodart
Merck
Proscar
Orexigen: Contrave FDA Panel Preview
TheStreet.com
Tue, 11/30/10 - 08:02 am
FDA
advisory panels
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Vivus
Spectrum expects FDA ruling on Fusilev by April 29
Yahoo/AP
Mon, 11/29/10 - 01:42 pm
FDA
Spectrum Pharmaceuticals
Fusilev
colon cancer
Merck KGaA Says FDA Extends Review of MS Pill in Setback Against Novartis
Bloomberg
Sat, 11/27/10 - 01:15 pm
Merck KGaA
FDA
MS
multiple sclerosis
Novartis
Darmstadt

Pages